Schedule 13G ownership disclosure
Eucrates Biomedical Acquisition Corp.
Security class unavailable · CUSIP: G3141W114
Event date: 2020-10-27
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 7.7800%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193805-20-001340
- Form type
- SC 13G
- Filer
- Eucrates Biomedical Acquisition Corp.
- CIK
- CIK 1822929
- Filed
- Oct 30, 2020
- Reporting period
- Oct 27, 2020
- Description
- Schedule 13G beneficial ownership